Good Publication Practice for Communicating Company-Sponsored Medical Research (GPP3)

Good Publication Practice for industry sponsored research was first published in 2003 and updated in 2009. This Good Publication Practice 3 Guideline (GPP3), published in 2015, builds on the earlier versions and reflects the changes that have occurred in legislation concerning dissemination of data from clinical trials, mainly focussed on the pharmaceutical industry.

The guidelines are intended to serve as a basis for publication professionals to establish transparent and ethical working practices within the pharmaceutical industry. The recommendations cover publications in peer-reviewed journals and presentations at scientific congresses. The guidelines do not cover regulatory documents, medical education programs, marketing or advertising materials as these are regulated or accredited by specific national or regional authorities.

GPP3 is intended for individuals or organisations that contribute to the publication of research sponsored or supported by pharmaceutical industry.

The six core principles of GPP are integrity, transparency, completeness, accuracy, accountability and responsibility.

The GPP3 Steering Committee has established, in conjunction with the International Society for Medical Publication Professionals (ISMPP) an online repository of questions and answers and relevant resources on publication practice:

Referentie: Wendy P. Battisti et al. Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3. Annals of  Internal Medicine 2015;163(6):461-464.

Tagged in